- About
- Membership
- Publications
- Events
- Awards
- Jobs
- Industry
- Resources
- Donate
Where are my child's stem cells?
That's what 200-300 Dutch parents were asking when they discovered Cryo-Save was on the brink of bankruptcy and had transferred their children's umbilical cord cells long-term cryo storage to the PBKM FamiCord Group in Poland. A FamiCord representative confirmed that 2% of approximately 230,000 clients’ samples did not arrive at the laboratories. Cryo-Save now faces a transplant law investigation in response to transporting these samples without the client's consent. READ MORE
Want to prevent this happening to your biobank? Check out ISBER's best practice guide
University College London (UCL) and the Royal Free London Hospital have announced a new ovarian tissue bank to preserve the fertility of girls and women about to undergo treatment for cancer.
The publically funded initiative will be led by UCL academic Dr. Paul Hardiman (UCL Institute of Women's Health) and consultant in obstetrics and gynaecology at the Royal Free Hospital in London, with consultation by Society for Cryobiology Fellow, Prof. Barry Fuller, head of research for the UCL Division of Surgery, and Prof. Mark Lowdell, UCL director of Cellular Therapeutics.
Worldwide there have been approximately 100 live births following ovarian tissue preservation and subsequent reimplantation on the remaining ovary or into the lining of the abdominal cavity.
Dr. Hardiman, tissue bank director, said: “We have modelled our protocols on how it is done at the Rigshospitalet, Copenhagen, one of the largest hospitals in Denmark, where they have been freezing human ovarian tissue since 1999. This is a well-established method in Europe, the US and Japan but the UK has lagged behind and patients often faced having to go abroad and pay to receive this treatment. At a time when patients need to concentrate on life-saving therapies this intervention needs to take place as quickly as possible.”
“What makes the Royal Free London so ideally suited to provide this service is that we have a unique mix of facilities and expertise in tissue freezing and cell therapy including Professor Barry Fuller, head of research for the UCL Division of Surgery and Interventional Science and Professor Mark Lowdell, director of Cellular Therapeutics. We are also a leading kidney and liver transplant centre and the principle UK centre for cell and tissue medicines which has helped facilitate approval from the Human Tissue Authority. We are very grateful for the support from the Royal Free Charity over the past seven years which funded Natalie Getreu*, a PhD student, who played an important role in enabling us to bring this to patients.”
*Society for Cryobiology student member, Natalie Getreu, presented her PhD research for the Ovarian Tissue Bank at CRYO2017 and CRYO2016.
Prof. W. John Armitage has recently been awarded an OBE for services to corneal transplantation in the Queen's New Year Honours list.
John is the Head of Research and Development for Ocular Tissue, NHS Blood and Transplant, Emeritus Professor, Bristol Medical School, University of Bristol, and former Director of Bristol Tissue Bank, which comprised the Bristol Eye Bank and Bristol Heart Valve Bank.
John completed his PhD in cardiac cryopreservation and research posts in Cambridge, UK and Oak Ridge National Laboratory, USA, before joining the Department of Opthamology in Bristol, UK, where he set up the Bristol Eye Bank to carry out research into corneal preservation.
The Bristol Eye Bank, one of the largest eye banks in Europe, is home to the UK's Corneal Transplant Service (CTS), which provides corneas to hospitals across the UK. Since 1986 the CTS has provided corneal transplants for over 70,000 patients through the UK's National Health Service (NHS). Although funded by the NHS, management of the eye bank remained at Bristol until 2015, at which time it was transferred to the National Health Service Blood and Transplant (NHSBT), the public body overseeing all blood, organ, and tissue transplants in the UK.
One of the major breakthroughs of the CTS was the introduction of 34°C (93°F) organ culture storage, which extended the life of transplants from a few days, to approximately four weeks. This transformed the face of corneal transplantation in the UK by improving logistics and supply, allowing transplants to be scheduled weeks in advance, as opposed to emergency surgery.
Speaking of his award, John said, "I am delighted to have my work recognised in this way, which also reflects the significant impact of the work of the Bristol Eye Bank and acknowledges the collective effort of NHS Blood and Transplant (NHSBT) and Bristol University staff, ophthalmology colleagues in Bristol Eye Hospital and hospitals throughout the UK, and the support of the Royal College of Ophthalmologists. However, above all, it is the thoughtfulness and generosity of the families of eye donors, without whom corneal transplantation would not be possible, that truly merit the thanks of patients and their doctors."
John is the current President of the European Eye Bank Association, of which he was a founding member, Associate Editor of Cryobiology, and a long time member and former Governor of the Society for Cryobiology.
Guest Post by Jason Acker, President of the Society for Cryobiology.
Job Title: Postdoctoral Fellow
Location: Center for Engineering in Medicine
Massachusetts General Hospital & Harvard Medical School
Closing date: December 2017
Did you know that for every ONE patient that receives a heart transplant in the USA, TEN hearts from organ donors are wasted because they cannot be transplanted in time?